N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Influence of Keratinized Tissue Width and Attached Gingiva Width on Root Coverage in Patients With Recession Defects: A Prospective Clinical Study

Sponsor: Postgraduate Institute of Dental Sciences Rohtak • ClinicalTrials.gov ID: NCT07576439

Registry updated: 2026-09-18
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

To evaluate the association between the width of keratinized tissue and attached gingiva with root coverage outcomes in RT1 gingival recession defects of maxillary and mandibular anterior teeth treated with subepithelial connective tissue graft (CTG) using a minimally invasive technique : modified vestibular incision subperiosteal tunnel access(m-VISTA). OBJECTIVES 1. PRIMARY OBJECTIVES 1. To analyze relation and association at 3 and 6 months outcomes in terms of CRC, mRC and gingival margin position with baseline parameters including width of keratinized tissue and width of attached gingiva, after providing mucogingival plastic surgery in the form of m-VISTA+CTG for the treatment of RT1recession defects. 2. To evaluate 3 and 6 months outcomes (percentage of root coverage, width of keratinized tissue and width of attached gingiva), after providing mucogingival plastic surgery in the form of m-VISTA+CTG for the treatment of RT1recession defects. 3. To access the long-term stability of gingival margin achieved from 3 months to 6 months. 2. SECONDARY OBJECTIVES 1. To access recession depth (RD), recession width (RW), probing pocket depth (PPD), mid buccal clinical attachment loss (bCAL), change in gingival thickness (GT) at baseline, at 3 months and 6 months. 2. To access patient related outcomes measures (PROM) in pain and hypersensitivity in teeth with gingival recession undergoing recession coverage.

Interventions

  • Vestibular incision subperiosteal tunnel access with connective tissue graft in treating RT 1 gingival recession defects (Procedure)
    the aim of this prospective clinical study is to determine if anatomical factors such as keratinized tissue width and attached gingiva width influence recession defects coverage of RT1 recession treated with minimally invasive surgical technique along with connective tissue graft. Keratinized tissue width and attached gingiva width are considered important for maintaining gingival health and long-term stability after root coverage. However, there is limited and unclear evidence on how much keratinized or attached gingiva is actually needed for successful root coverage. Most previous studies have focused on soft tissue thickness rather than these parameters.

Eligibility criteria

Inclusion Criteria: 1. Patients with Millers class Ⅰ and II / RT1 isolated recession defects in labial maxillary and mandibular anterior teeth region. 2. Recession depth ≥2mm 3. Systemically healthy individuals. 4. Age \>18 years old. 5. Full mouth bleeding and plaque score ≤20% 6. Patients who agreed to participate in the study and signed an informed consent form. Exclusion Criteria: 1. Patients having systemic disease such as hypertension, diabetes, hyperthyroidism or on medication that influence the outcome of periodontal therapy. 2. Patient with active periodontal disease 3. Smokers and tobacco users 4. Mal-aligned tooth with recession. 5. Patients who had already undergone root coverage procedure on the selected site. 6. Pregnant and lactating females 7. Involved tooth with trauma from occlusion. 8. Involved tooth with prosthesis. 9. Endodontically involved/ RCT treated tooth 10. Tooth with cervical abrasion / undetectable CEJ/ carious

Conditions

Gingival Recessions

Locations

  • Post Graduate Institute of Dental Sciences — Rohtak, Haryana, India
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record